Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)

Đang chuẩn bị liên kết để tải về tài liệu:
Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)

Ðức Long 176 8 pdf

Platinum-based systemic chemotherapy is the treatment of choice for patients with advanced urothelial carcinoma (UC). Although no chemotherapeutic regimen is established as a second-line therapy, recent studies reported that methotrexate, vinblastine, Adriamycin and cisplatin (MVAC) elicited a significant response in patients who failed gemcitabine and platinum (GP) chemotherapy. |

Đang chuẩn bị liên kết để tải về tài liệu:
Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)

Nocturnal penile erections: A retrospective study of the role of RigiScan in predicting the response to sildenafil in erectile dysfunction patients

Sequence heterogeneity in the core and NS5A region of hepatitis C Virus (HCV) and IL-28B polymorphisms in predicting treatment response among chronic HCV genotype 4 infected Egyptian patients

A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer

An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy

PDXGEM: Patient-derived tumor xenograftbased gene expression model for predicting clinical response to anticancer therapy in cancer patients

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients

Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST

Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer

Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

Đang chuẩn bị liên kết để tải về tài liệu: Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)

Nocturnal penile erections: A retrospective study of the role of RigiScan in predicting the response to sildenafil in erectile dysfunction patients

Sequence heterogeneity in the core and NS5A region of hepatitis C Virus (HCV) and IL-28B polymorphisms in predicting treatment response among chronic HCV genotype 4 infected Egyptian patients

A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer

An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy

PDXGEM: Patient-derived tumor xenograftbased gene expression model for predicting clinical response to anticancer therapy in cancer patients

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients

Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST

Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer

Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

Đang chuẩn bị liên kết để tải về tài liệu:
Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)